• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press Releases Translations

泰国颁授Prince Mahidol Award予DNDi创始人Bernard Pécoul医生,以表彰他对公共卫生的贡献

Home > Press Releases Translations

泰国颁授Prince Mahidol Award予DNDi创始人Bernard Pécoul医生,以表彰他对公共卫生的贡献

Dr Bernard Pécoul
曼谷/吉隆坡 — 12 Nov 2020
  • 中文
    • English
    • ไทย
    • 中文
    • اللغة العربية
    • Español
    • Português
    • 日本語

鉴于DNDi在医学与全球卫生课题上的贡献,DNDi执行董事加入成为奖历届得奖者之一。

有鉴于国际非营利性医学研究组织 ,Drugs for Neglected Diseases initiative (DNDi) 创办人兼执行董事Bernard Pécoul医生推动全球被忽视疾病研究的杰出贡献,泰国正式颁授2020年度Prince Mahidol Award于Pécoul医生。

Prince Mahidol Award基金会每年都会表彰在医学和全球公共卫生领域取得杰出成就的科学与健康领域领导人物。历届获奖者包括Anthony Fauci博士(美国)、Barry J. Marshall教授(澳大利亚)、Harald zur Hausen教授(德国)、Satoshi Omura博士(日本)和屠呦呦教授(中国)。

“能够加入成为Prince Mahidol Award历届得主,为此我感到无比地荣幸,” Pécoul医生说道。“这个奖项对我来说也具有非常特殊的意义:我的职业生涯始于泰国。35年前,我在泰国的难民营开始工作。而正是在那里,我亲眼见证了医疗上的忽视,也因此而促使我和许多合作伙伴一起创建了DNDi。”

自2003年DNDi成立以来,Bernard Pécoul医生一直领导着DNDi直到今天。1999年,当医疗人道主义组织 “无国界医生”(MSF)获得诺贝尔和平奖时,该组织决定将部分奖金用于成立一种创新、可替代性、且非营利的模式,为全球数亿被忽视的疾病患者探索与开发药物。也因此,DNDi应运而生。它的创始伙伴包括无国界医生(MSF),世界卫生组织(WHO),以及由五个国际公共卫生机构组成的团体–其中亦包括马来西亚卫生部。

From left to right: Professor Supat Vanichakarn, M.D. Secretary-General of the Prince Mahidol Award Foundation under the Royal Patronage; Professor Dr Prasit Watanapa, M.D., Ph.D. Dean of Faculty of Medicine Siriraj Hospital, Mahidol University; Professor Vicharn Panich, M.D. Chairman of the International Award Committee of the Prince Mahidol Award Foundation; Mr. Tanee Sangrat, Director-General of the Department of Information, Ministry of Foreign Affairs, and Chairman of the Sub-Committee on Public Relations of the Prince Mahidol Award Foundation; Dr John R. MacArthur Regional Director, Southeast Asia (SEAS) Regional Office, US Centers for Disease Control and Prevention; Dr Taraneh Shojaei Regional Counsellor in Global Health, South-East Asia, at the French Embassy

“Prince Mahidol Award对于Pécoul医生来说,无疑是一份对他无私付出一个非常大的肯定。对他来说,无论是富人亦或者是穷人,他都是一视同仁,将所有人的健康卫生条件优先放在第一考量上。这一份他坚定不移的决心。”马来西亚卫生总监兼DNDi董事会成员Tan Sri Dr Noor Hisham Abdullah说道。“其中一个取得成果的例子是DNDi与我们在马来西亚的密切合作;DNDi和马来西亚卫生部在为丙型肝炎患者争取并扩大可负担的治疗方面,取得非常巨大的进展。”

在Pécoul医生的领导下,DNDi为利什曼病、昏睡病和南美锥虫病 – 一些世界上极度常被忽视的疾病 – 以及疟疾还有感染艾滋病毒的儿童提供了八种新的治疗方法。除此之外,该组织与全球近数百个公共和私人机构合作,开发了多项强大的项目组合。这项项目涵盖了这些疾病的药物开发、临床研究和普及治疗;其中也包括河盲症、足菌肿和丙型肝炎。另一方面, DNDi也与WHO协力一同在2016年创办了Global Antibiotic Research and Development Partnership(GARDP)。今天他们是独立非营利组织,主要进行对健康造成极大威胁的抗生素耐药性感染开发新的治疗方法。

Pécoul医生将其职业生涯的大部分时间都投入到了药物普及宣导和创建一个主要是为了患者医疗需求,而并非以利益为中心的替代研发模式。在1983年,他以医生的身份加入无国界医生组织(MSF),在非洲、拉丁美洲和亚洲进行实地医疗工作。1988年,他与其他人共同创立了无国界医生(MSF)附属的非政府组织Epicentre,主要专注于研究流行病学。此后,他在1991年成为无国界医生(MSF)法国的总干事,然后在1998年至2003年期间担任无国界医生(MSF)Campaign for Access to Essential Medicines的创始总监。

“Pécoul医生坚信,中低收入国家可以通过合伙关系和合作的力量,成功地建立属于自己的解决方案来解决自己的公共卫生问题。” DNDi驻马来西亚的东南亚地区办事处主任Jean-Michel Piedagnel说道。“这个奖项对DNDi在泰国和东南亚地区长期的发展给予恰到其分的认可;我们相信它将有助于我们在本区域的的工作,并同时在应对丙型肝炎、抗生素耐药性、骨痛热症以及其他本地区面临的主要公共卫生挑战上,从中强化我们的重要伙伴关系。”

鉴于受到目前的疫情影响,今年的获奖者将被正式邀请参加在2022年在泰国举办的颁奖典礼。而在近期内,获奖者亦会受邀为他们的成就进行在线演讲。

关于DNDi:

The Drugs for Neglected Diseases initiative(DNDi) 是一个以病患需求为出发点的非营利性药物研发组织。组织主要为被忽视疾病患者研发新的治疗处方,这其中包括昏热病、南美锥虫病、利什曼病、丝虫病、足菌肿、儿艾滋病毒/艾滋病、丙型肝炎病毒的治疗方法。DNDi希望通过药物开发和注册,推出价格合理、安全有效的泛基因型直接作用抗病毒药物(DAAs);也希望通过倡导带动政策变革和提高政治意愿,来达到消除使用DAAs药物的障碍,并且从中实现全球丙型肝炎(HCV)治疗普及化,让更多人受惠。

关于Prince Mahidol Award 基金会:

1992年1月1日,Bhumibol Adulyadej国王陛下批准,由Siriraj医院医学系提议成立了马希敦王子奖(Prince Mahidol Award)基金会,以纪念Songkla王子殿下百年诞辰。该基金会的成立是为了纪念王子殿下以及表彰他作为 “泰国现代医学和公共卫生之父 “的模范贡献而设立的。

媒体联系:

DNDi 东南亚办事处
Molly Jagpal
电话: +60 (0)12 546 8362
电邮: mjagpal@dndi.org  

DNDi 日内瓦办事处
Frederic Ojardias
电邮: fojardias@dndi.org

Photo credit: FBBVA, Prince Mahidol Foundation

Asia Thailand

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License